The IgG and IgM from the sera of patients convalescing from severe COVID-19 inhibited pseudo-virus infection by over 50% at a 720-fold dilution, and almost completely inhibited pseudo-virus infection at a 90-fold dilution. This evidence concerns the gene CD40LG and COVID-19.